Heparin-induced thrombocytopenia (HIT) is a serious postoperative complication of low-molecular-weight heparin (LWMH) prescribed following surgery and recent evidence based guidelines recommend routine platelet count monitoring for all at-risk patients. With the implementation of these guidelines this clinical study demonstrated a significant improvement (2 – 56% p<0.05) in HIT diagnosis in postoperative patients receiving LMWH. An international survey showed a lack of awareness of heparin-induced thrombocytopenia and its management.
AntonelliD., FaresL., AneneC.2000Enoxaparin associated with huge abdominal wall hematomas: a report of two casesThe AmericanSurgeon66(8) 797–800
2.
BaglinT., BarrowcliffeT.W., CohenA., GreavesM.2006Guidelines on the use and monitoring of heparinBritish Journal of Haematology133(1) 19–34
3.
BicklerP., BrandesJ., LeeM., BozicK., ChesbroB., ClaassenJ.2006Bleeding complications from femoral and sciatic nerve catheters in patients receiving low molecular weight heparinAnesthesia & Analgesia103(4) 1036–1037
4.
BoshkovL.K., WarkentinT.E., HaywardC.P., AndrewM., KeltonJ.G.1993Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studiesBritish Journal of Haematology84(2) 322–328
5.
British National Formulary2008London, BMJ Publishing
6.
BurgessJ.K., LindemanR., ChestermanC.N., ChongB.H.1995Single amino acid mutation of Fc gamma receptor is associated with the development of heparin-induced thrombocytopeniaBritish Journal of Haematology91(3) 761–766
7.
ChongB.H.1995Heparin-induced thrombocytopeniaBritish Journal of Haematology89(3) 431–439
8.
ClagettG.P., AndersonF.A.Jr, HeitJ., LevineM.N., WheelerH.B.1995Prevention of venous thromboembolismChest108(4 Suppl) 312S–334S
9.
DickinsonL.D., MillerL.D., PatelC.P., GuptaS.K.1998Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumorsNeurosurgery43(5) 1074–1081
10.
Gerhard-HermanM.2001Heparin-induced thrombocytopeniaCurrent Treatment Options in Cardiovascular Medicine3(3) 215–224
11.
HoudeJ.P., SteinbergG.1999Intrahepatic hemorrhage after use of low-molecular-weight heparin for total hip arthroplastyJournal of Arthroplasty14(3) 372–374
12.
ImbertiD., AgenoW., DentaliF., GiorgiP.M., CrociE., GarciaD.2006Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluationJournal of Thrombosis and Haemostasis4(5) 1037–1041
13.
KingD.J., KeltonJ.G.1984Heparin-associated thrombocytopeniaAnnals of Internal Medicine100(4) 535–540
14.
LeyvrazP.F., BachmannF., HoekJ.1991Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparinBritish Medical Journal303(6802) 543–548
15.
LilikakisA.K., PapapolychroniouT., MacherasG., MichelinakisE.2006Thrombocytopenia and intracerebral complications associated with low-molecular-weight heparin treatment in patients undergoing total hip replacement. A report of two casesJournal of Bone and Joint Surgery (Am)88(3) 634–638
16.
MohrD.N., SilversteinM.D., MurtaughP.A., HarrisonJ.M.1993Prophylactic agents for venous thrombosis in elective hip surgery. Meta-analysis of studies using venographic assessmentArchives of Internal Medicine153(19) 2221–2228
17.
ShaiebM.D., WatsonB.N., AtkinsonR.E.1999Bleeding complications with enoxaparin for deep venous thrombosis prophylaxisJournal of Arthroplasty14(4) 432–438
18.
SternS.H., WixsonR.L., O'ConnorD.2000Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplastyJournal of Arthroplasty15(2) 153–158
19.
WarkentinT.E.1999Heparin-induced thrombocytopenia: a clinicopathologic syndromeThrombosis and Haemostasis82(2) 439–447
20.
WolfH.1994Low-molecular-weight heparinMedical Clinics of North America78(3) 733–743
